Synergy of ruthenium metallo-intercalator, [Ru(dppz)2(PIP)]2+, with PARP inhibitor Olaparib in non-small cell lung cancer cells
Poly(ADP-ribose) polymerase (PARP) are critical DNA repair enzymes that are activated as part of the DNA damage response (DDR). Although inhibitors of PARP (PARPi) have emerged as small molecule drugs and have shown promising therapeutic effects, PARPi used as single agents are clinically limited to...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Article |
| 出版: |
Nature Publishing
2023
|
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|